Keywords: thalomid, trial, myeloma, delayed, celgene, announced, its

Thalomid trial in myeloma delayed?

Article | 09 April 2001

Print This

Celgene has announced that its Total Therapy II trial of Thalomid(thalidomide), which was initiated in October 1998 and was designed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in